Rhelion Life Sciences Corp.
TRUFF
$0.02
$0.008.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.96% | 21.20% | 33.58% | 46.85% | 48.86% |
| Total Depreciation and Amortization | -53.94% | -65.13% | -50.01% | -33.23% | -18.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 437.28% | -33.98% | -64.53% | -77.53% | -84.70% |
| Change in Net Operating Assets | -59.81% | -52.23% | 1,901.07% | 23.27% | 855.68% |
| Cash from Operations | -62.11% | -42.71% | 64.69% | 40.51% | 55.00% |
| Capital Expenditure | 73.74% | 75.91% | 72.70% | 79.58% | 25.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18,778.57% | -6,038.33% | -6,300.00% | -1,991.03% | -46.15% |
| Cash from Investing | -131.82% | -65.99% | -17.69% | 59.49% | 20.92% |
| Total Debt Issued | -99.21% | -63.44% | -95.04% | -95.04% | -- |
| Total Debt Repaid | -464.54% | -189.34% | -214.99% | -247.98% | 38.01% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -271.12% | -259.10% | -379.36% | -397.95% | 311.71% |
| Foreign Exchange rate Adjustments | 82.89% | 309.07% | 535.75% | 6,514.29% | 186.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.13% | -84.79% | 29.85% | 22.23% | 63.40% |